開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
谷歌(GOOG.O):在安卓上推出安全密碼和通行密鑰傳輸功能。
2026-09-11
谷歌(GOOG.O):在安卓上推出安全密碼和通行密鑰傳輸功能。
返回
其他消息
2026-09-10
China's National Medical Products Administration (NMPA) approved semaglutide injection (brand: Nuoheying®) for metabolic dysfunction‑associated steatohepatitis (MASH) with moderate-to-severe liver fibrosis (F2–F3) in non-cirrhotic adults, making it the first and only GLP-1RA approved for MASH.
China's National Medical Products Administration (NMPA) approved semaglutide injection (brand: Nuoheying®) for metabolic dysfunction‑associated steatohepatitis (MASH) with moderate-to-severe liver fibrosis (F2–F3) in non-cirrhotic adults, making it the first and only GLP-1RA approved for MASH.
2026-09-10
Binglun Environment said at an investor event its data-center chiller business posted confirmed receipts of about RMB800 mln in 1H, up 43% YoY, lifting the segment to 22% of total revenue and making it a primary growth driver. Continued strength in North American data-center construction is supporting related product profitability.
Binglun Environment said at an investor event its data-center chiller business posted confirmed receipts of about RMB800 mln in 1H, up 43% YoY, lifting the segment to 22% of total revenue and making it a primary growth driver. Continued strength in North American data-center construction is supporting related product profitability.
Chat with us
, powered by
LiveChat